A. Elía,L. Saldain,S. I. Vanzulli,L. A. Helguero,C. A. Lamb,V. Fabris,G. Pataccini,P. Martínez-Vazquez,J. Burruchaga,I. Caillet-Bois,E. Spengler,G. Acosta Haab,M. Liguori,A. Castets,S. Lovisi,M. F. Abascal,V. Novaro,J. Sánchez,J. Muñoz,J. M. Belizán,M. C. Abba,H. Gass,P. Rojas and C. Lanari. Beneficial effects of mifepristone treatment in breast cancer patients selected by the progesterone receptor isoform ratio: Results from the MIPRA trial. Clinical Cancer Research. 2022:10.1158/1078-0432.Ccr-22-2060.
